ALHC Q1 2026 Earnings Call Summary | Stock Taper
Logo
ALHC

ALHC — Alignment Healthcare, Inc.

NASDAQ


Q1 2026 Earnings Call Summary

May 1, 2026

Summary of Alignment Healthcare, Inc. Q1 2026 Earnings Call

1. Key Financial Results and Metrics

  • Health Plan Membership: Increased to 284,800, a 31% year-over-year growth.
  • Total Revenue: Reached $1.2 billion, up 33% year-over-year.
  • Adjusted Gross Profit: $146 million, with a Medical Benefit Ratio (MBR) of 88.2%, improving by 20 basis points year-over-year.
  • Adjusted SG&A: $108 million, representing 8.7% of revenue, a 60 basis point improvement year-over-year.
  • Adjusted EBITDA: $38 million, an 88% increase year-over-year, with an adjusted EBITDA margin of 3.1%.

2. Strategic Updates and Business Highlights

  • The company is focused on scaling operations and enhancing clinical engagement, with significant investments in automation and AI to improve efficiency.
  • A notable improvement in claims auto adjudication rates from less than 15% to over 60% year-to-date.
  • The company is addressing a recent CMS rule change that temporarily affected inpatient admissions, which has now been resolved.
  • Continued emphasis on growth among high-acuity populations, with a clinical-first approach that distinguishes Alignment Healthcare from competitors.

3. Forward Guidance and Outlook

  • 2026 Membership Guidance: Expected to be between 294,000 and 299,000 members.
  • Revenue Guidance: Projected between $5.16 billion and $5.21 billion, reflecting a 31% year-over-year growth at the midpoint.
  • Adjusted Gross Profit: Expected between $620 million and $650 million.
  • Adjusted EBITDA: Forecasted between $138 million and $163 million.
  • For Q2 2026, membership is expected to be between 288,000 and 290,000, with revenue projected at $1.30 billion to $1.32 billion.

4. Bad News, Challenges, or Points of Concern

  • The company faced a temporary disruption in inpatient admissions due to a workflow issue related to a CMS rule change, which impacted financial performance in Q1.
  • There is an ongoing risk associated with the mix of membership, particularly with high-acuity populations, which could lead to higher inpatient admissions.
  • The overall trend in healthcare costs is expected to exceed the 2.48% rate increase from CMS, potentially leading to pressures on margins and the need for benefit adjustments in the future.

5. Notable Q&A Insights

  • Management confirmed that the inpatient admission issue was an internal workflow problem, not a systemic issue, and has since been resolved.
  • There is cautious optimism regarding risk adjustment for new members, with a focus on tracking performance closely.
  • The company is considering expanding its product offerings, including potentially bringing supplemental benefits in-house to improve margins.
  • Discussions around the final rate notice indicated that while the 2.48% increase is manageable, it does not reflect the higher trends in healthcare costs, which could necessitate future adjustments in strategy.

Overall, Alignment Healthcare reported strong growth and operational improvements in Q1 2026, while also addressing challenges related to inpatient admissions and the broader healthcare cost environment. The company remains optimistic about its growth trajectory and strategic initiatives moving forward.